Disease management now centers on more precise, context-driven diagnostics, restrained empiric antifungal use, echinocandin-focused therapy, and risk-based ophthalmologic evaluation aligned across global and US guidelines.
James Wilson, DO, FACP, FAWM, CTropMed
Advertisement
Wilson is a proud Navy veteran and osteopathic physician trained, certified and practicing in Internal Medicine, Infectious Diseases, and Critical Care Medicine after his time as a US Navy flight surgeon where he participated while stationed and deployed overseas in Humanitarian Aid; Disaster Relief (HA;DR) missions. He has also been recognized as a Fellow in the American College of Physicians (FACP), Fellow in the Academy of Wilderness Medicine (FAWM), and is Certified in Tropical Medicine and Hygiene (CTropMed) and Military Tropical Medicine (MTM). Currently, he also serves as Clinical Adjunct Faculty in immunology and infectious diseases at Rush Medical College (RMC), as well as general clinical medicine and point of care ultrasound (POCUS) at Touro University College of Osteopathic Medicine in California (TUCOM-CA).
Articles by James Wilson, DO, FACP, FAWM, CTropMed
Although COVID-19 has receded quite a bit from the minds of many, it still remains a virus that can present serious morbidity and mortality. Here is a review of clinical treatment strategies by an intensivist when seeing patients with severe COVID-19.
The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.
Advertisement
Latest Updated Articles
The Lingering Threat: Managing Severe COVID-19 in the Postpandemic EraPublished: June 12th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Interpreting FDA’s Request for Warning Labels on Influenza Vaccines About Febrile Seizures
2
Measles Update: January 30, 2026
3
HIV Spending for Fiscal Year 2026: The Latest Update
4
FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease
5